CN104622907A - Use of starfish extract for preparing composition for promoting collagen proliferation - Google Patents
Use of starfish extract for preparing composition for promoting collagen proliferation Download PDFInfo
- Publication number
- CN104622907A CN104622907A CN201410625151.6A CN201410625151A CN104622907A CN 104622907 A CN104622907 A CN 104622907A CN 201410625151 A CN201410625151 A CN 201410625151A CN 104622907 A CN104622907 A CN 104622907A
- Authority
- CN
- China
- Prior art keywords
- extract
- asterias amurensis
- amurensis lutken
- collagen
- purposes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 79
- 102000008186 Collagen Human genes 0.000 title claims abstract description 70
- 108010035532 Collagen Proteins 0.000 title claims abstract description 70
- 229920001436 collagen Polymers 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 230000001737 promoting effect Effects 0.000 title abstract description 9
- 241000258957 Asteroidea Species 0.000 title abstract 5
- 230000035755 proliferation Effects 0.000 title abstract 2
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 241000257468 Asterias amurensis Species 0.000 claims description 95
- 206010020718 hyperplasia Diseases 0.000 claims description 23
- 230000002500 effect on skin Effects 0.000 claims description 18
- 210000002950 fibroblast Anatomy 0.000 claims description 18
- 210000004027 cell Anatomy 0.000 claims description 16
- 150000004676 glycans Chemical class 0.000 claims description 16
- 229920001282 polysaccharide Polymers 0.000 claims description 16
- 239000005017 polysaccharide Substances 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000003814 drug Substances 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000000865 liniment Substances 0.000 claims description 3
- 229940040145 liniment Drugs 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 210000001626 skin fibroblast Anatomy 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000037319 collagen production Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 15
- 238000000034 method Methods 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 12
- 239000006071 cream Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 229910019142 PO4 Inorganic materials 0.000 description 6
- 239000008366 buffered solution Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 102400001368 Epidermal growth factor Human genes 0.000 description 5
- 101800003838 Epidermal growth factor Proteins 0.000 description 5
- 229940116977 epidermal growth factor Drugs 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 206010020880 Hypertrophy Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 241000208140 Acer Species 0.000 description 2
- 241000959915 Archaster typicus Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- -1 and especially skin Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000012757 fluorescence staining Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 2
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- FBVVGPMIPAZFAW-RZVRUWJTSA-N (2S)-pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1.OC(=O)[C@@H]1CCCN1 FBVVGPMIPAZFAW-RZVRUWJTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BWXSUNOYDCORSM-UOXYZBCYSA-N (2s)-1-hydroxypyrrolidine-2-carboxylic acid;(2s,4r)-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound O[C@H]1CN[C@H](C(O)=O)C1.ON1CCC[C@H]1C(O)=O BWXSUNOYDCORSM-UOXYZBCYSA-N 0.000 description 1
- KUNFMZSTKSLIEY-GRHHLOCNSA-N (2s)-2-azanyl-3-phenyl-propanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=CC=C1 KUNFMZSTKSLIEY-GRHHLOCNSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- YXXURDJTDAAEPH-UHFFFAOYSA-N 2-aminopropanethioic s-acid Chemical compound CC(N)C(S)=O YXXURDJTDAAEPH-UHFFFAOYSA-N 0.000 description 1
- DEFJQIDDEAULHB-UHFFFAOYSA-N Alanyl-alanine Chemical compound CC(N)C(=O)NC(C)C(O)=O DEFJQIDDEAULHB-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001427960 Astrophytum asterias Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241000258955 Echinodermata Species 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000512 collagen gel Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- NHDHVHZZCFYRSB-UHFFFAOYSA-N pyriproxyfen Chemical compound C=1C=CC=NC=1OC(C)COC(C=C1)=CC=C1OC1=CC=CC=C1 NHDHVHZZCFYRSB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- YRWWOAFMPXPHEJ-OFBPEYICSA-K sodium L-ascorbic acid 2-phosphate Chemical compound [Na+].[Na+].[Na+].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] YRWWOAFMPXPHEJ-OFBPEYICSA-K 0.000 description 1
- 229940048058 sodium ascorbyl phosphate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 108010045269 tryptophyltryptophan Proteins 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses an application of starfish extract in preparing a composition for promoting collagen proliferation. The starfish extract contains various active ingredients, can effectively improve the collagen production capacity of skin fibroblasts, and the extraction method can effectively improve the economic value of the starfish and has no pollution, so the starfish extract can be effectively applied to skin care products and cosmetics.
Description
Technical field
The present invention relates to a kind of purposes promoting collagen hyperplasia, particularly a kind of Asterias amurensis Lutken extract promotes the purposes of the compositions of collagen hyperplasia in preparation.
Background technology
Asterias amurensis Lutken is the title of the animal of a guiding principle under Echinodermata, has surprising regeneration capacity, can not only bear the peduncle broken again, and some Asterias amurensis Lutken even can own regeneration one is complete by the peduncle be truncated new individuality.Asterias amurensis Lutken is distributed in the coastal area in Asia, North America, Australia more, and habitat is generally the seabed of husky mud substrate.Taiwan belongs to island, and Aquatic product enriches, and also has multiple Asterias amurensis Lutken, such as common in the Intertidal zone in Penghu style of calligraphy characterized by hollow strokes maple Asterias amurensis Lutken (Archaster typicus).Asterias amurensis Lutken of many uses, some Asterias amurensis Lutken, except can being provided as the material of food materials or processed food, is also a kind of often by the Chinese crude drug used; Asterias amurensis Lutken, because its high nutritive value, is also processed to mash feed.In medical usage, Asterias amurensis Lutken can be used to make harmless alternative blood plasma after refining; In addition, there is research to point out, the compositions such as the EPA contained by Asterias amurensis Lutken, to the treatment of hyperlipidemia, cardiovascular disease, have certain effect.
Collagen protein is a kind of biological polymer substance, is the protein that vertebrates in-vivo content is maximum, in human body, then account for 1/3rd of gross protein.Mainly being present in the extracellular matrix (extracellular matrix) of connective tissue, is cell and intercellular support.The skin, cartilage, cornea, blood vessel wall, internal organs etc. of human body are all containing collagen protein, and especially skin, collagen protein provides support the intensity of Skin Cell, keeps compacting and elasticity of skin.But with age and the accumulation of suffered external unfavorable factor, the ability that dermal fibroblasts generates collagen protein can reduce, once the speed that collagen protein runs off is greater than the speed that it generates, skin just can produce wrinkle, the phenomenon such as lax.
Therefore, the collagen protein generative capacity of replenishing collagen or lifting cell is the important topic of skin care.Be no lack of the product of replenishing collagen on the market, comprise modes such as smearing with external, inject or eat.But the molecule of collagen protein is large, the not easily horny layer of transdermal, the skin corium dermal fibroblasts that mode of smearing almost cannot make collagen protein arrive it to act on; If with the direct replenishing collagen of mode of injection, although the microgroove of skin can be reduced immediately, but the ferment that this injection enters in the collagen protein meeting body in body decomposes, need regular injection, process is complicated and cost is high, and injectable collagen albumen may produce immunological rejection, increase the risk on using.If carry out replenishing collagen with the edible food being rich in collagen protein, after collagen protein enters the intestines and stomach, structure i.e. destroyed formation of its triple helix wins peptide more, and many victory peptides cut into micromolecule via Digestive system, finally resolve into amino acid again.Health no doubt can utilize these amino acid synthetic proteins, but is not limited to collagen protein, therefore the limited efficiency of actual replenishing collagen.
In view of this, the collagen protein generative capacity system promoting human dermal fibroblast blast cell comparatively replenishing collagen more can guarantee effectively produce and utilize collagen protein, but there is no a kind of safe and effective product on the market at present, can promote the generation of collagen protein.
Summary of the invention
Edge this, one of the present invention object is to provide a kind of Asterias amurensis Lutken extract the promotes collagen hyperplasia purposes of compositions in preparation, and wherein this Asterias amurensis Lutken extract comprises water solublity polysaccharides, and this water solublity polysaccharides is Asterias amurensis Lutken polysaccharide.This Asterias amurensis Lutken extract can promote the collagen hyperplasia rate of cell, and this cell is dermal fibroblasts and comes from the mankind; Asterias amurensis Lutken extract of the present invention can promote that the collagen hyperplasia rate of this dermal fibroblasts is more than 80%.
In one embodiment of this invention, this Asterias amurensis Lutken extract is extracted by Asterias amurensis Lutken live body and obtains, and is that Asterias amurensis Lutken live body is via made by freezing, pulverizing, high-temperature extraction and alcohol extraction.
In addition, the compositions prepared by Asterias amurensis Lutken extract of the present invention can be externally applied liniment or external pharmaceuticals or external skin care products or cosmetics.It should be noted that, described externally applied liniment or external pharmaceuticals include but not limited to ointment or cream or adhesive preparation or attach stype or the artificial organ containing active component.In addition, described external skin care products or cosmetics can include but not limited to astringent or cosmetic cream or emulsion or foundation cream or foundation emulsion or sunscreen or bath shampoo.
Another object of the present invention is to provide a kind of promoter promoting hyperplasia collagen protein, and it comprises Asterias amurensis Lutken extract, and wherein this cell is dermal fibroblasts, and this Asterias amurensis Lutken extract comprises the water solublity polysaccharides of more than 89% (w/w).
Asterias amurensis Lutken extract of the present invention contains active component, and can promote that dermal fibroblasts generates collagen protein significantly.Asterias amurensis Lutken extract of the present invention, the Asterias amurensis Lutken extract source that it comprises is natural, and preparation method is simple, pollution-free, therefore effectively can be applied to product and the cosmetics of maintenance skin.
Embodiments of the present invention are further illustrated below by graphic for cooperation; following cited embodiment illustrates invention Speciality and application of the present invention; but not to limit scope of the present invention; anyly have the knack of this those skilled in the art; without departing from the spirit and scope of the present invention; when doing a little change and retouching, therefore protection scope of the present invention is when being as the criterion depending on the scope described in accompanying claims.
Accompanying drawing explanation
Fig. 1 represents the extraction procedure figure of Asterias amurensis Lutken extract of the present invention.
Fig. 2 represents that Asterias amurensis Lutken extract of the present invention promotes collagen hyperplasia ability.
Fig. 3 represents that Asterias amurensis Lutken extract of the present invention promotes that dermal fibroblasts generates the fluorescence staining microscope figure of collagen protein, wherein (a) control group; B () is with the Asterias amurensis Lutken extract process of 5% (v/v); C () processes with epidermal growth factor (EGF, 5ng/mL).
Detailed description of the invention
For confirming that Asterias amurensis Lutken extract of the present invention can promote collagen hyperplasia, the present invention be by gentle, operate easy method and prepare Asterias amurensis Lutken extract, and analyze the active component in Asterias amurensis Lutken extract.In addition, also by Asterias amurensis Lutken extract of the present invention and dermal fibroblasts co-cultivation, assess the excellent generative capacity of collagen protein that Asterias amurensis Lutken extract of the present invention promotes dermal fibroblasts.
Definition
Asterias amurensis Lutken extract of the present invention is the collagen protein production rate that can promote dermal fibroblasts, and the content being enough to realize this object is defined as " effective dose ".The factors known according to those who are familiar with this art decides by the content that can realize this object, the effect of the body weight of such as consumer, general body state, age, sex and constituent substrate.
Embodiment 1: the preparation of Asterias amurensis Lutken extract
Style of calligraphy characterized by hollow strokes maple Asterias amurensis Lutken (Archaster typicus) used in the present invention is collected from area, Penghu, Taiwan.About the preparation of Asterias amurensis Lutken extract, please refer to Fig. 1.In time preparing Asterias amurensis Lutken extract of the present invention, first, collect Asterias amurensis Lutken live body and in time catching, be placed in-4 DEG C ~-20 DEG C environment stored frozen immediately, by freezing Asterias amurensis Lutken live body grinding (as step S1); Then, by through grinding Asterias amurensis Lutken with 1:3 ~ 1:20 (w:v) ratio water-soluble and be heated to 90 DEG C ~ 100 DEG C extraction 1 ~ 5 hour (as step S2); After high-temperature extraction, filter with centrifugal action (4,300g) and get its supernatant (as step S3); Then, the ethanol adding 3 times of volumes in 4 DEG C makes polysaccharides precipitate and maintains 16-24 hour (as step S4); After alcohol settling effect, filter with centrifugal action (4,300g rpm) and get its precipitate (as step S5); Then, this precipitate is dissolved in (as step S6) in the water of 10-15 times of volume; Finally, filter with centrifugal action (4,300g rpm) and get its supernatant (as step S7), namely obtaining Asterias amurensis Lutken extract of the present invention.
Embodiment 2: Asterias amurensis Lutken extract water solublity polysaccharides is analyzed
Total polysaccharides content of Asterias amurensis Lutken extract of the present invention measures with phenol-sulphuric acid (phenol-sulfuric acid) method.The Glucose standards solution of 100 μ L Asterias amurensis Lutken extracts and variable concentrations (0,25,50,75,100 and 125mg/mL) is mixed in test tube.Then 0.5mL phenol solution is added and 2.5mL sulphuric acid reacts.Test tube is measured its light absorption value at 750nm with spectrum signal transducer (spectrophotometer).
Analysis result shows, water solublity polysaccharides containing 2.23% (w/v) in the Asterias amurensis Lutken extract solution of 2.5% (w/v), the water solublity polysaccharides content therefore contained by known Asterias amurensis Lutken extract of the present invention is approximately 89% (w/w).
Embodiment 3: Asterias amurensis Lutken extract promotes collagen hyperplasia capability analysis
Human skin fibroblast CCD-966SK (Human skin fibroblast cells is cultivated with the minimal essential medium (MEM) containing 10% hyclone (FBS), purchased from Foodstuff Industrial and Development Inst.) in 24-porose disc, the concentration of human skin fibroblast is 4 × 10
4cells/well.Culture medium is upgraded after 24 hours cultivate.Experimental group is dilute Asterias amurensis Lutken extract (concentration be respectively 0.2,0.4,0.6,0.8 and 1.0mg/mL) with phosphate buffered solution (phosphate buffer saline, PBS) and add in each hole.Control group does not then add Asterias amurensis Lutken extract, and in 37 DEG C, cultivate 48 hours under 5% carbon dioxide conditions after get its supernatant, experiment find Asterias amurensis Lutken extract promote collagen protein be created on 48 hours within to increase in time and linear relevant.
Use
collagen Assay Kit (Bicolor Life Science Assays, Northern Ireland, UK) analyzes the content of water solublity I-type collagen.At room temperature, by supernatant 100 μ L and the 1mL of said method gained
stain mixes 30 minutes.Then with 15,000g centrifugal action 10 minutes to form collagen deposit thing.Remove centrifugal after supernatant and collagen deposit thing is dissolved in 1mL basic solvent.Its light absorption value at wavelength 540nm is measured with spectrum signal transducer.The quantity of collagen protein calculates with water-solubility collagen standard curve (standard without disease Corii Bovis seu Bubali skin I-type collagen, the U.S.).
Please refer to Fig. 2, this figure is that Asterias amurensis Lutken extract of the present invention promotes the analysis that collagen protein generates, and find that experimental group is with after the Asterias amurensis Lutken extract process of 1mg/mL, per unit human skin fibroblast generates the collagen protein of 45.25 ρ g; Far above the amount generating 24.48 ρ g collagen protein in control group, therefore, Asterias amurensis Lutken extract of the present invention obviously confirms effectively to promote that collagen hyperplasia rate is more than at least 80%, goodly reaches 84.8%.
Embodiment 4: Asterias amurensis Lutken extract promotes the fluorescence immunoassay of collagen hyperplasia
Fix human skin fibroblast after CCD-966SK30 minute with the phosphate buffered solution (PBS) containing 1% paraformaldehyde (para-formaldehyde, Sigma, France) in addition, and rinse in phosphate buffered solution.This cell 24 hours are processed respectively with Asterias amurensis Lutken extract of the present invention (5% (v/v)), epidermal growth factor (5ng/mL), control group cell then processes with normal saline solution (Phosphate Buffered Saline, PBS).(1/2000 dilutes for the cell this distinctly processed through Asterias amurensis Lutken extract or epidermal growth factor again and water resistant dissolubility I-type collagen rat monoclonal antibody, abcam, Britain) co-cultivation is in the phosphate buffered solution containing 1% (w/v) bovine serum albumin (PBS).Then, clean up hill and dale with phosphate buffered solution and with the anti-rat IgG antibody of fluorescein (fluorescein) labelling (1/200 dilutes, KPL, the U.S.) co-cultivation 60 minutes under no light conditions.After phosphate buffered solution cleaning, observe with fluorescence conjugated focusing microscope (Leica TSC SP2, Germany).
Please refer to Fig. 3, this figure is the fluorescence staining microscope figure that dermal fibroblasts generates collagen protein, wherein (a) represents control group cell, b () representative is with the cell of 5% (v/v) Asterias amurensis Lutken extract process, (c) represents the cell processed with epidermal growth factor (5 ng/mL).In figure, arrow represents collagen protein.Clearly visible by Fig. 3, through the cell of Asterias amurensis Lutken extract of the present invention process, the growing amount of collagen protein is significantly increased compared with control group cell, also compared with the more collagen protein of the Hemapoiesis of epidermal growth factor process, therefore, Asterias amurensis Lutken extract of the present invention confirms the hypertrophy that effectively and significantly can promote collagen protein further.
Meanwhile, Asterias amurensis Lutken extract of the present invention also comprises multiple amino acid and trace element, and analysis result please refer to following table.
The amino acid content of table 1, Asterias amurensis Lutken extract
| Amino acid | Content (mg/g) |
| Hydroxyl proline Hydroxyproline | 5.08 |
| Aminothiopropionic acid Cystine | 4.27 |
| Histidine Histidine | 5.39 |
| Glutamic acid Glutamic acid | 54.08 |
| Bright amino acid Leucine | 24.19 |
| Alanine Alanine | 21.7 |
| Rely amino acid Lysine | 26.07 |
| This amino acid Serine | 18.67 |
| Different bright amino acid Isoleucine | 15.18 |
| Phenylalanine Phenylalanine | 13.87 |
| Soviet Union amino acid Threonine | 17.69 |
| Aspartic acid Aspartic acid | 37.11 |
| Pick amino acid Valine | 16.77 |
| Tryptophan Tryptophan | 5.81 |
| Proline Proline | 17.31 |
| Taurine Taurine | 12.35 |
| MET Methylthianine | 8.69 |
| Spermine acid Arginine | 39.99 |
| Glycine Glycine | 33.71 |
The micronutrient levels of table 2, Asterias amurensis Lutken extract
| Trace element | Content (μ g/g) |
| Copper Cu | 5.6 |
| Plumbous Pb | <0.2 |
| Manganese Mn | 74.5 |
| Zinc Zn | 77.6 |
| Nickel | 6.05 |
| Calcium Ca | 153000 |
| Magnesium Mg | 533 |
| Phosphorus P | 125 |
| Cobalt Co | 1.08 |
| Selenium Se | 2.16 |
| Chromium Cr | 1.40 |
| Cadmium Cd | 28.30 |
| Silicon Si | 5.30 |
| Germanium Ge | 5.90 |
| Strontium Sr | 1933 |
Embodiment 5: produce the cosmetics and/or pharmaceuticals that promote collagen hyperplasia with Asterias amurensis Lutken extract
Cosmetics and/or the pharmaceuticals such as Water-In-Oil (O/W) neutral cream and gel can be produced with Asterias amurensis Lutken extract.The neutral cream oil phase about about 30 ~ 50% of O/W, do not have too greasy impression, Asterias amurensis Lutken extract can be added in formula, there is the effect promoting skin collagen hypertrophy, by as shown in table 3 for the formula that the Asterias amurensis Lutken extract of gained of the present invention is applied to neutral cream:
Table 3, formula containing Asterias amurensis Lutken extract cream
| Oil content: | Octadecanol | 6.0％ |
| Stearic acid | 2.0％ | |
| Agnolin | 4.0％ | |
| Shark alkane | 9.0％ | |
| Octyl group 12 alkanol | 10.0％ | |
| Wetting agent | PEG 1500 | 4.0％ |
| 1,3-fourth dioxane | 6.0％ | |
| Interfacial agent | Glyceryl monostearate | 2.0％ |
| POE (25) spermaceti alcohol ester | 3.0％ | |
| Antiseptic | 0.01％ | |
| Antioxidant | 0.01％ | |
| Spice | 0.02％ |
| Active component | Asterias amurensis Lutken extract | 0.1％ |
| Pure water | 53％ |
Slowly add the composition of oil phase at high speeds, to be emulsified complete after, containing the cream of Asterias amurensis Lutken extract, this cream at room temperature can preserve 6 months.
The Asterias amurensis Lutken extract of gained of the present invention also can be used for producing collagen gel, and this gel also can reach the effect promoting skin collagen hypertrophy, and the formula of this gel is as shown in table 4:
Table 4, formula containing Asterias amurensis Lutken extract gel
| Wetting agent | Dipropylene glycol | 7.0％ |
| PEG 1500 | 5.0％ | |
| Water soluble polymer | Methylcellulose | 0.2％ |
| Interfacial agent | POE(15)oleyl alcohol ether | 1.0％ |
| Alkaline agent | Sodium hydroxide | 0.1％ |
| Antiseptic | 0.01％ | |
| Antioxidant | 0.01％ | |
| Spice | 0.02％ | |
| Active component | Asterias amurensis Lutken extract | 0.1％ |
| Pure water | 83％ |
Embodiment 6: produce the essence promoting collagen hyperplasia with Asterias amurensis Lutken extract
Asterias amurensis Lutken extract of the present invention can be used for producing the essence promoting collagen hyperplasia, comprises an Asterias amurensis Lutken extract component, a moisture-keeping functions composition component, a whitening function composition component and an antibacterial.The essence of promotion collagen hyperplasia is using deep seawater as substrate, and its content is in fact about 40wt%, wherein, the total weight of the essence of this promotion collagen hyperplasia, the content of this Asterias amurensis Lutken extract component is between 15wt% to 20wt%; This moisture-keeping functions composition component includes but not limited to be selected from the group be made up of glucoprotein (Glygoprotein), hyaluronic acid, 1,3 butylene glycol or 1,3-PD, and its content is between 10wt% to 20wt%; This whitening function composition component includes but not limited to be selected from the group be made up of Folium Vaccinii vitis-idaeae foline (Arbutin), kojic acid (Kojic Acid), vitamin C sodium phosphate (Sodium Ascorbyl Phosphate) or Magnesium Ascorbyl Phosphate (Magnesium Ascorbyl Phosphate), and its content is between 10wt% to 20wt%; And the content of this antibacterial is in fact 0.1wt% to 0.2wt%.
Asterias amurensis Lutken extract of the present invention is for the effect producing essence: in essence, Asterias amurensis Lutken extract component contains water solublity polysaccharide, i.e. Asterias amurensis Lutken polysaccharide, the collagen hyperplasia rate of dermal fibroblasts can be promoted, and also containing multiple amino acid and trace element in Asterias amurensis Lutken extract, can activating skin cells, moisture-keeping functions component in collocation essence and whitening function component, can promote essence maintenance effect to skin further.
In sum, Asterias amurensis Lutken extract of the present invention has various active composition, and be rich in water solublity polysaccharides, the collagen hyperplasia of dermal fibroblasts can be promoted, in addition, the manufacture method of Asterias amurensis Lutken extract of the present invention is simple and easy, pollution-free, therefore not only can effectively utilize natural resources and not to environmental pollution, also can provide a high activity and the skin care product raw material of safety.
Only, above describing is only preferred embodiment of the present invention and illustrates, is allly skillful in this those skilled in the art when can do other all improvement according to above-mentioned explanation, and only these changes still belong in spirit of the present invention and following defined the scope of the claims.
Claims (12)
1. Asterias amurensis Lutken extract promotes a purposes for the compositions of collagen hyperplasia in preparation, and wherein this Asterias amurensis Lutken extract comprises water solublity polysaccharides.
2. purposes as claimed in claim 1, wherein this Asterias amurensis Lutken extract can promote the collagen hyperplasia rate of cell.
3. purposes as claimed in claim 2, wherein this cell is dermal fibroblasts.
4. purposes as claimed in claim 3, wherein this dermal fibroblasts comes from the mankind.
5. the purposes as described in claim 3 or 4, wherein this Asterias amurensis Lutken extract promotes that the collagen hyperplasia rate of this dermal fibroblasts is more than 80%.
6. purposes as claimed in claim 1, wherein this water solublity polysaccharides is Asterias amurensis Lutken polysaccharide.
7. purposes as claimed in claim 1, wherein this Asterias amurensis Lutken extract is extracted by Asterias amurensis Lutken live body and obtains.
8. purposes as claimed in claim 1, wherein this Asterias amurensis Lutken extract is that Asterias amurensis Lutken live body is via made by freezing, pulverizing, high-temperature extraction and alcohol extraction.
9. purposes as claimed in claim 1, wherein said composition is externally applied liniment, external pharmaceuticals, external skin care products or cosmetics.
10. promote a promoter for hyperplasia collagen protein, comprise Asterias amurensis Lutken extract.
11. promoter as claimed in claim 10, wherein this cell is dermal fibroblasts.
12. promoter as claimed in claim 10, wherein this Asterias amurensis Lutken extract comprises the water solublity polysaccharides of more than 89% (w/w).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102141511 | 2013-11-14 | ||
| TW102141511A TW201517930A (en) | 2013-11-14 | 2013-11-14 | Use of starfish extract for manufacture of composition for enhancing secretion of collagen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104622907A true CN104622907A (en) | 2015-05-20 |
Family
ID=53202469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410625151.6A Pending CN104622907A (en) | 2013-11-14 | 2014-11-07 | Use of starfish extract for preparing composition for promoting collagen proliferation |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN104622907A (en) |
| TW (1) | TW201517930A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125476A (en) * | 2015-10-19 | 2015-12-09 | 广州科玛生物科技有限公司 | Anti-wrinkle essence and preparing method thereof |
| CN105147591A (en) * | 2015-10-19 | 2015-12-16 | 广州科玛生物科技有限公司 | Anti-wrinkle face cream and preparation method thereof |
| CN105147590A (en) * | 2015-10-19 | 2015-12-16 | 广州科玛生物科技有限公司 | Anti-wrinkle eye cream and preparation method thereof |
| CN105168112A (en) * | 2015-10-19 | 2015-12-23 | 广州科玛生物科技有限公司 | Anti-wrinkle toner and preparation method thereof |
| CN105287331A (en) * | 2015-10-19 | 2016-02-03 | 广州科玛生物科技有限公司 | Anti-wrinkle cleansing lotion and preparation method thereof |
| KR101640799B1 (en) * | 2016-03-11 | 2016-07-19 | 아무르콜라겐(주) | Method for preparing starfish extract and cosmetic composition comprising starfish extract |
| TWI593418B (en) * | 2016-01-26 | 2017-08-01 | 大江生醫股份有限公司 | Use of starfish extract for manufacture of composition for reducing ultraviolet spots, production of porphyrin and sebum production in the skin |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109966196A (en) * | 2019-03-01 | 2019-07-05 | 王珊珊 | A kind of natural Essence and preparation method thereof with healing |
-
2013
- 2013-11-14 TW TW102141511A patent/TW201517930A/en unknown
-
2014
- 2014-11-07 CN CN201410625151.6A patent/CN104622907A/en active Pending
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125476A (en) * | 2015-10-19 | 2015-12-09 | 广州科玛生物科技有限公司 | Anti-wrinkle essence and preparing method thereof |
| CN105147591A (en) * | 2015-10-19 | 2015-12-16 | 广州科玛生物科技有限公司 | Anti-wrinkle face cream and preparation method thereof |
| CN105147590A (en) * | 2015-10-19 | 2015-12-16 | 广州科玛生物科技有限公司 | Anti-wrinkle eye cream and preparation method thereof |
| CN105168112A (en) * | 2015-10-19 | 2015-12-23 | 广州科玛生物科技有限公司 | Anti-wrinkle toner and preparation method thereof |
| CN105287331A (en) * | 2015-10-19 | 2016-02-03 | 广州科玛生物科技有限公司 | Anti-wrinkle cleansing lotion and preparation method thereof |
| CN105147590B (en) * | 2015-10-19 | 2018-05-22 | 广州科玛生物科技股份有限公司 | A kind of anti-wrinkle eye cream and preparation method thereof |
| CN105168112B (en) * | 2015-10-19 | 2018-06-05 | 广州科玛生物科技股份有限公司 | A kind of crease-resistant toner and preparation method thereof |
| CN105125476B (en) * | 2015-10-19 | 2018-06-05 | 广州科玛生物科技股份有限公司 | A kind of anti-wrinkle essence and preparation method thereof |
| CN105147591B (en) * | 2015-10-19 | 2018-06-05 | 广州科玛生物科技股份有限公司 | A kind of crease-resistant face cream and preparation method thereof |
| CN105287331B (en) * | 2015-10-19 | 2018-07-31 | 广州科玛生物科技股份有限公司 | A kind of crease-resistant mildy wash and preparation method thereof |
| TWI593418B (en) * | 2016-01-26 | 2017-08-01 | 大江生醫股份有限公司 | Use of starfish extract for manufacture of composition for reducing ultraviolet spots, production of porphyrin and sebum production in the skin |
| KR101640799B1 (en) * | 2016-03-11 | 2016-07-19 | 아무르콜라겐(주) | Method for preparing starfish extract and cosmetic composition comprising starfish extract |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201517930A (en) | 2015-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104622907A (en) | Use of starfish extract for preparing composition for promoting collagen proliferation | |
| CN106727164B (en) | A kind of moisture-keeping composition and its preparation method and application | |
| CN102762189B (en) | Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression | |
| CN108143702A (en) | Efficient whitening and moisturizing mask liquid, mask and preparation method of mask liquid | |
| CN103585097B (en) | Epidermal growth factor-loaded bletilla rhizome polysaccharide compound, and preparation method and application thereof | |
| TWI594766B (en) | Collagen production promoter, hyaluronic acid production promoter, fibroblast proliferation promoter and anti-wrinkle agent | |
| CN103845272B (en) | Earth-worm extractive as raw material with resisting age of skin effect and its preparation method and application | |
| CN104490732B (en) | A kind of anti-aging scale collagen polypeptide facial mask and preparation method thereof | |
| WO2007007989A1 (en) | Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same | |
| CN101766656A (en) | Combination containing mushroom polysaccharide and preparation method thereof | |
| JP2008266260A (en) | Composition containing hyaluronic acid generation promoting factor obtainable from amber, and its use | |
| CN106726917B (en) | A kind of eyeware products and solution for lenses and contact lenses | |
| KR20150120426A (en) | Cosmetic composition containing a brown alga extract, a yeast extract and ascorbic acid | |
| CN100536858C (en) | Substances extracted from dictyotales, Preparation method therefor, and compositions containing same | |
| CN103479567A (en) | Epidermal growth factor complex lipidosome, and preparation method and application of lipidosome | |
| FR2912313A1 (en) | Combination, useful for the preparation of cosmetic or dermatological composition to prevent and/or treat skin aging, comprises wheat germ extract and esculin | |
| CN109864910A (en) | A kind of cordyceps sinensis composition with anti-senescence function and preparation method thereof and anti-aging skin care product | |
| CN105246498A (en) | Method for producing a mixture of neutral oligosaccharides extracted from flaxseed | |
| Porto da Rocha et al. | Effects of a vitamin pool (vitamins A, E, and C) on the tissue necrosis process: experimental study on rats | |
| CN108902438B (en) | Cod peptide and enzymolysis extraction method thereof | |
| CN107174536A (en) | A kind of salamander face beautifying skin protection product and preparation method thereof | |
| CN105213270A (en) | Whitening spot-eliminating composition | |
| WO2004052388A2 (en) | Composition and method to whiten and exfoliate skin | |
| CN115737478B (en) | Application of desert algae skin care raw material in preparation of skin soothing agent | |
| CN102018650B (en) | Plant active essence |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150520 |